HLA-DRA anticorps
-
- Antigène Voir toutes HLA-DRA Anticorps
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp HLA-DRA est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC)
- Attributs du produit
- Expected molecular weight of target: 254 kDa
- Purification
- Affinity purification
- Immunogène
- Recombinant protein of human HLA-DRA
- Isotype
- IgG
- Top Product
- Discover our top product HLA-DRA Anticorps primaire
-
-
- Indications d'application
- WB 1:500-1:2000, IHC 1:50-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.4
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C.
-
- Antigène
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
- Autre désignation
- HLA-DRA (HLA-DRA Produits)
- Synonymes
- anticorps HLA-DRA1, anticorps MLRW, anticorps DR-alpha, anticorps HLA-DRA, anticorps Mamu-DRA1, anticorps major histocompatibility complex, class II, DR alpha L homeolog, anticorps major histocompatibility complex, class II, DR alpha, anticorps hla-dra.L, anticorps HLA-DRA, anticorps MAMU-DRA, anticorps BOLA-DRA
- Poids moléculaire
- 29 kDa
- ID gène
- 3122
- UniProt
- P01903
- Pathways
- TCR Signaling, CXCR4-mediated Signaling Events
-